Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
13%
OVERLAP
BY WEIGHT
9
# OF OVERLAPPING
HOLDINGS
PSCH
70
HOLDINGS
13%
ALSO IN SBIO
SBIO
94
HOLDINGS
11%
ALSO IN PSCH
SECTOR DRIFT (PSCH minus SBIO)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PSCH |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
ALKERMES PLC | 3.3% | 2.7% | 2.7% |
 |
KRYSTAL BIOTECH, INC. | 2.6% | 2.5% | 2.5% |
|
ACADIA PHARMACEUTICALS INC | 2.3% | 2.6% | 2.3% |
|
PROTAGONIST THERAPEUTICS, INC. | 2.4% | 2.0% | 2.0% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 1.5% | 1.4% | 1.4% |
PSCH Overweight Relative to SBIO
|
CORCEPT THERAPEUTICS INC | 5.1% |
|
TELEFLEX INC | 3.9% |
|
MERIT MEDICAL SYSTEMS INC | 3.8% |
|
GLAUKOS CORP | 3.6% |
|
ADMA BIOLOGICS, INC. | 3.0% |
|
TRANSMEDICS GROUP, INC. | 2.9% |
|
INTEGER HOLDINGS CORPORATION | 2.8% |
|
TG THERAPEUTICS INC | 2.7% |
|
RADNET INC | 2.7% |
|
PRESTIGE BRANDS HOLDINGS INC | 2.4% |
PSCH Underweight Relative to SBIO
|
RHYTHM PHARMACEUTICALS, INC. | -3.6% |
|
AVIDITY BIOSCIENCES INC | -3.5% |
|
AXSOME THERAPEUTICS, INC. | -3.2% |
|
NUVALENT, INC. CLASS A | -3.1% |
 |
MERUS N.V. | -3.0% |
|
VIKING THERAPEUTICS, INC. | -2.6% |
|
CYTOKINETICS INC | -2.5% |
|
AKERO THERAPEUTICS, INC. | -2.5% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -2.4% |
|
ARCELLX, INC. | -2.4% |